Jerry St Peter to spearhead NicOx expansion in US
Aims to build an international ophthalmology company
St Peter has extensive knowledge of the ophthalmology market in the US. Most recently, he developed the commercial unit of Inspire Pharmaceuticals, an ophthalmology focused company acquired by Merck & Co for US$430m in May 2011.
In collaboration with NicOx’s European headquarters, St Peter will be responsible for identifying and evaluating North American opportunities that can be exploited globally to build NicOx’s late-stage ophthalmic portfolio. He will also lead the development of NicOx’s US ophthalmology business.
NicOx announced earlier this week that it had acquired 11.8% of the shares of Altacor, a privately held ophthalmology company based in the UK, and entered into an exclusive option agreement to acquire the remaining shares.
Michele Garufi, chairman and ceo of NicOx, said: ‘Jerry has been working with NicOx as a consultant for the past five months, helping us in the ongoing evaluation of a number of ophthalmology companies and products. He will be a key asset in the creation and future expansion of our presence in the US as we work towards delivering our strategy of building an international ophthalmology company.’
St Peter joined Inspire in 2003 and held the positions of senior vice president, Ophthalmology Business Unit, svp, sales and managed markets and vp of sales.
Prior to joining Inspire, St Peter held a number of leadership positions for Muro Pharmaceutical, a private ophthalmic, pulmonary, asthma and allergy specialist pharmaceutical company.
You may also like
Pharmaceutical
Ardena strengthens executive team to drive its next phase of growth
Ghent, Belgium, 4 May 2026 – Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and commercial reach globally
Pharmaceutical
Backed by investments exceeding $1 billion, PCI Pharma Services announces major expansion of US sterile fill-finish and drug-device delivery combination capabilities
As pharma manufacturers prioritise US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging
Media
Romaco to debut Maximus 400 tablet coater with automatic baffle adjustment at Interpack
The Maximus 400 tablet coater is the first to automatically adjust baffle geometry as tablet bed volume increases, with an optional energy recovery system cutting consumption by up to 50%, alongside the VENTILUS Lab fluid bed processor, capable of reducing batch processing times by 25%
Manufacturing
SCIEX expands integrated software ecosystem with six mass spectrometry workflow collaborations
The firm has announced six software collaborations designed to unify instrument control, data processing and compliance within a single analytical environment, with more partnerships set to be revealed at ASMS 2026